Skip to main content

Table 1 The co-distribution of a risk marker (High/Low risk) and adverse event (+/- Toxicity) in response to standard treatment in two hypothetical patient populations (A, B).

From: Challenges in implementing individualized medicine illustrated by antimetabolite therapy of childhood acute lymphoblastic leukemia

Population A

Outcome

Low risk

High risk

RR/OR

- Toxicity

969

20

9.9/10.8

+Toxicity

9

2

Precision 2/(20+2): 9.1%

Sensitivity 2/(9+2): 18%

Population B

Outcome

Low risk

High risk

RR/OR

- Toxicity

535

446

9.9/10.2

+Toxicity

2

17

Precision 17/(446+17): 3.7%

Sensitivity 17/(2+17): 89%

  1. Precision and sensitivity calculated as explained in the main text. RR: Relative Risk; OR: Odds Ratio